The Biomanufacturing Excellence Act of 2025 aims to establish a National Biopharmaceutical Center of Excellence to enhance the United States' capabilities in biopharmaceutical manufacturing, which utilizes biological systems to produce medicines. This legislation underscores the critical role of biotechnology in national security, health, and economic stability, with a goal of reducing dependence on foreign supply chains.